Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 51-60 of 134

Page
per page
  1. Imiquimod maleate
    B1187 Imiquimod maleate
    Summary: Immune response modifier
      Soluble in DMSO
  2. Suprofen
    B2133 Suprofen
    Target: COX
    Summary: dual COX-1/COX-2 inhibitor
      insoluble in H2O; ≥82.8 mg/mL
  3. IMD 0354
    B1587 IMD 0354
     1 Citation
    Summary: IKKβ inhibitor
      insoluble in H2O; ≥100.8 mg/mL
  4. ML130 (Nodinitib-1)
    B1646 ML130 (Nodinitib-1)
    Target: NOD1
    Summary: Potent and selective inhibitor of NOD1
      Soluble in DMSO
  5. Sodium 4-Aminosalicylate
    B1643 Sodium 4-Aminosalicylate
    Summary: NF-κB inhibitor
      ≥10.65 mg/mL
  6. egg white lysozyme (19-36) [Gallus gallus]
    A1065 egg white lysozyme (19-36) [Gallus gallus]
    Summary: Dissolution of cell wall
      insoluble in H2O; insoluble in EtOH; ≥402.3 mg/mL
  7. ferritin heavy chain fragment [Multiple species]
    A1069 ferritin heavy chain fragment [Multiple species]
    Summary: Ferritin heavy chain fragment
      ≥107.7 mg/mL
  8. IgG light chain variable region [Homo sapiens]/IgM/kappa antibody [Mus musculus]
    A1070 IgG light chain variable region [Homo sapiens]/IgM/kappa antibody [Mus musculus]
    Summary: IgG light chain region
      ≥81 mg/mL
  9. immunoglobulin light chain variable region fragment [Homo sapiens]
    A1071 immunoglobulin light chain variable region fragment [Homo sapiens]
    Summary: Immunoglobulin light chain fragment
      ≥86.4 mg/mL
  10. immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus]
    A1072 immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus]
    Summary: Immunoglobulin light chain fragment
      ≥112.2 mg/mL

Items 51-60 of 134

Page
per page